Background illustration for clinical trials search

Paid Clinical Trials Wilmington

Discover 162 paid clinical trials in Wilmington, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: Myrtle Beach SC, Durham NC, Charlottesville VA,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase 2, Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Myrtle Beach SC, Charlotte NC, Lancaster PA,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase 3, Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

for
Metastatic Castration-resistant Prostate Cancer,
Location: Myrtle Beach SC, Durham NC, Columbus OH,
Sponsor: K36 Therapeutics, Inc.

Sex: Male

Age: 18+

Code: NCT07103018

Phase 1, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Myrtle Beach SC, Charleston SC, Charlotte NC,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase 3, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Myrtle Beach SC, North Charleston SC, Charleston SC,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Myrtle Beach SC, Raleigh NC, Durham NC,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase 2, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Myrtle Beach SC, Raleigh NC, Charleston SC,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

for
Febrile Neutropenia, Non-myeloid Malignancy
Location: Myrtle Beach SC, Charlotte NC, Rock Hill SC
Sponsor: Coherus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04662892

Recruiting
Active & Responsive

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

for
Obesity, Overweight
Location: Wilmington NC, Monroe NC, Bristol TN, Jacksonville FL,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07607587

Phase 1, Recruiting
Active & Responsive

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

for
Diabetes Mellitus, Type 2
Location: Wilmington NC, North Charleston SC, Oxon Hill MD,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18 - 70+

Code: NCT07668388

Phase 2, Recruiting
Active & Responsive

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

for
Overweight, Obesity
Location: Wilmington NC, North Charleston SC, Greensboro NC,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07745504

Phase 3, Recruiting
Active & Responsive

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

for
Diabetes Mellitus, Type 2
Location: Wilmington NC, Greensboro NC, Newport News VA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07817251

Phase 3, Recruiting
Active & Responsive

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

for
Overweight, Obesity
Location: Wilmington NC, Raleigh NC, North Charleston SC,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07720271

Phase 3, Recruiting
Active & Responsive

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

for
Obesity
Location: Wilmington NC, Chapel Hill NC, North Charleston SC,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07339423

Phase 3, Recruiting
Active & Responsive

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for
Obesity, Knee Osteoarthritis (OA)
Location: Wilmington NC, North Charleston SC, Newport News VA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07481630

Phase 3, Recruiting

Cosmetic Evaluation of Lumpectomy Versus Oncolytic Mammoplasty With Bilateral Breast Reduction for Early Stage Breast Cancer

for
Breast Carcinoma
Location: Wilmington NC
Sponsor: Coastal Carolina Radiation Oncology

Sex: Female

Age: 50+

Code: NCT01400399

Recruiting

Prevail Global Study

for
Coronary Artery Disease
Location: Wilmington NC, Charleston SC, Greensboro NC,
Sponsor: Medtronic Vascular

Sex: All

Age: 18+

Code: NCT06535854

Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Wilmington NC, Mt. Pleasant SC, Lynchburg VA,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase 1, Phase 2, Recruiting

Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

for
Neurotrophic Keratitis
Location: Leland NC
Sponsor: BRIM Biotechnology Inc.

Sex: All

Age: 18+

Code: NCT05927428

Phase 2, Recruiting

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

for
Acne Scars
Location: Wilmington NC, Arlington VA, Alpharetta GA,
Sponsor: AbbVie

Sex: All

Age: 22+

Code: NCT07207369

Phase 3, Recruiting